Amazon.com's Retail Practices in India Under Scrutiny: Report
San Francisco: Regulators in India are investigating whether Amazon.com Inc may have circumvented restrictions placed on foreign investors by selling directly to domestic consumers, The Wall Street Journal on Friday, citing unidentified sources.
The Enforcement Directorate is looking into whether Amazon.com's local subsidiary may have sold directly to customers, but made it look as if the sales were made by other companies, the report said, quoting two people familiar with the matter.
India does not allow foreign firms to own majority stakes in retail companies that sell more than one brand. Amazon.com is allowed to operate there because it acts as a marketplace rather than a retailer, according to the report.
Amazon was not immediately available for comment.
The Seattle-based e-commerce company makes its money in India by charging third-party suppliers to use its website to sell some 17 million different products, from books to electronics. Asia's second-largest country is seen as strategically important to Amazon as it tries to ramp up growth and profits.
Amazon.com has said it plans to invest $2 billion (Rs 12,000 crore at 1 dollar = 60 rupees) more in India, where it has slashed prices, ramped up marketing and accelerated warehouse construction to try and take on local competitors.
Indian investigators are also examining whether Amazon exerts control over the prices of products sold on its website, one of the sources said.
"An ideal marketplace should not have any interference from the platform operator," the newspaper cited the person as saying.
Amazon.com shares dipped into negative territory in afternoon trading, down 65 cents at $345.30.
Copyright @ Thomson Reuters 2014
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.